Precision oncology trounces traditional tumor treatment in major meta-analysis. (Article in Health Imaging)
New era of personalized cancer drugs, say doctors (Article at BBC)
A list of more than 200 cancer drug information summaries from NCI. Consumer-friendly information about cancer drugs and drug combinations. (List)
Targeted therapies: Frequently asked questions (CANCER.GOV FAQ)
Cancer drugs approvals by year (Link at CenterWatch)
Personalized Medicine in Brief (Spring 2016)
Personalized Medicine in Brief (Fall 2015)
Biopharmaceutical companies’ personalized medicine research yields innovative treatments for patients (Link at Personalized Medicine Coalition)
A featured article in The Scientist magazine highlights CureMatch co-founder Dr. Razelle Kurzrock and her clinical use of personalized drug combinations therapies at the Center for Personalized Cancer Therapy at the University of California, San Diego. The advances in personalized cancer treatments appear to lead to better results for cancer patients. Check out the entire […]
New study published in ANTICANCER RESEARCH Journal offers potential proof-of-concept for precision medicine approach to cancer treatment. SAN DIEGO, CA – April 12, 2018: A new in vitro cancer study supports the concept of matched combination therapies as more effective treatment when compared to matched monotherapies or the current standard of care. Among the most […]
New study in The Oncologist supports the use of blood-based tumor DNA (liquid biopsies) in hepatocellular carcinoma (HCC) to facilitate personalized medicine. The CureMatch decision support platform matches personalized drug combinations for liver cancer patients. SAN DIEGO, CA – March 26, 2018: A new cancer study[1] reports that next-generation sequencing of circulating tumor DNA (ctDNA) can provide therapeutically […]